WILLIAM GORDON: Open Payments
NPI 1275780009 · TUCSON, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 13 payments from 6 companies in 2025. Trend: 2023 $578 · 2024 $487 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 5 | $244 |
| Alkermes, Inc. | 3 | $165 |
| Janssen Pharmaceuticals, Inc | 1 | $144 |
| E.R. Squibb & Sons, L.L.C. | 2 | $119 |
| ABBVIE INC. | 1 | $97 |
| Otsuka America Pharmaceutical, Inc. | 1 | $26 |
Products named: AUSTEDO XR, INVEGA SUSTENNA, LYBALVI, COBENFY, VRAYLAR, UZEDY, ARISTADA, ABILIFY MAINTENA.
Industry payments across AZ — which companies pay providers there.
